Valion Bio (VBIO) Revenue (2021 - 2026)
Valion Bio (VBIO) posted Revenue of $39000.0 for Q2 2026, down 51.25% on a QoQ basis from $80000.0 in Q4 2025, and down 54.65% year-over-year from $86000.0 in Q2 2025.
Powered by 
Analysis
Valion Bio (VBIO) Revenue (2021 - 2026) Analysis & Trends
Valion Bio has reported Revenue for 6 years, with the latest figure at $39000.0 in Q2 2026.
- On a quarterly basis, Revenue fell 54.65% year-over-year to $39000.0 in Q2 2026; TTM through Jun 2026 was $351000.0, a 24.03% decrease from a year earlier, with the FY2025 full-year figure at $382000.0, down 51.03% from the prior year.
- Revenue was $39000.0 for Q2 2026 at Valion Bio, down from $80000.0 in the prior quarter.
- The five-year high for Revenue was $528000.0 in Q2 2022, with the low at $39000.0 in Q2 2026.
- Average Revenue over 5 years is $248117.6, with a median of $180000.0 recorded in 2024.
- The sharpest annual moves came in 2022 and 2025: Revenue soared 97.01% in 2022, then sank 79.04% in 2025.
- Over 5 years, Revenue stood at $408000.0 in 2022, then slipped by 12.5% to $357000.0 in 2023, then plunged by 49.58% to $180000.0 in 2024, then slumped by 55.56% to $80000.0 in 2025, then tumbled by 51.25% to $39000.0 in 2026.
- The last three Revenue figures came in at $39000.0 (Q2 2026), $80000.0 (Q4 2025), and $146000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 10.05 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 7.80 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 3.33 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 4.29 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 1.52 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 145.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 1.29 Bn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 2.74 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 1.44 Mn |
| 10 | Valion Bio | 298,792.01 | -1.90 Mn | -45,000.00 | 39,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 39,000.00 |
| Dec 31, 2025 | 80,000.00 |
| Sep 30, 2025 | 146,000.00 |
| Jun 30, 2025 | 86,000.00 |
| Mar 31, 2025 | 70,000.00 |
| Dec 31, 2024 | 180,000.00 |
| Sep 30, 2024 | 126,000.00 |
| Jun 30, 2024 | 140,000.00 |
| Mar 31, 2024 | 334,000.00 |
| Dec 31, 2023 | 357,000.00 |
| Sep 30, 2023 | 282,000.00 |
| Jun 30, 2023 | 161,000.00 |
| Mar 31, 2023 | 376,000.00 |
| Dec 31, 2022 | 408,000.00 |
| Sep 30, 2022 | 477,000.00 |
| Jun 30, 2022 | 528,000.00 |
| Mar 31, 2022 | 428,000.00 |
| Dec 31, 2021 | 389,000.00 |
| Sep 30, 2021 | 277,000.00 |
| Jun 30, 2021 | 268,000.00 |